Cargando…
Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison
Ubiquitin-specific-processing protease 7 (USP7) is a promising target protein for cancer therapy, and great attention has been given to the identification of USP7 inhibitors. Traditional virtual screening methods have now been successfully applied to discover USP7 inhibitors aiming at reducing costs...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835315/ https://www.ncbi.nlm.nih.gov/pubmed/36631899 http://dx.doi.org/10.1186/s13321-022-00675-8 |
_version_ | 1784868642276507648 |
---|---|
author | Shen, Wen-feng Tang, He-wei Li, Jia-bo Li, Xiang Chen, Si |
author_facet | Shen, Wen-feng Tang, He-wei Li, Jia-bo Li, Xiang Chen, Si |
author_sort | Shen, Wen-feng |
collection | PubMed |
description | Ubiquitin-specific-processing protease 7 (USP7) is a promising target protein for cancer therapy, and great attention has been given to the identification of USP7 inhibitors. Traditional virtual screening methods have now been successfully applied to discover USP7 inhibitors aiming at reducing costs and speeding up time in several studies. However, due to their unsatisfactory accuracy, it is still a difficult task to develop USP7 inhibitors. In this study, multiple supervised learning classifiers were built to distinguish active USP7 inhibitors from inactive ligands. Physicochemical descriptors, MACCS keys, ECFP4 fingerprints and SMILES were first calculated to represent the compounds in our in-house dataset. Two deep learning (DL) models and nine classical machine learning (ML) models were then constructed based on different combinations of the above molecular representations under three activity cutoff values, and a total of 15 groups of experiments (75 experiments) were implemented. The performance of the models in these experiments was evaluated, compared and discussed using a variety of metrics. The optimal models are ensemble learning models when the dataset is balanced or severely imbalanced, and SMILES-based DL performs the best when the dataset is slightly imbalanced. Meanwhile, multimodal data fusion in some cases can improve the performance of ML and DL models. In addition, SMOTE, unbiased decoy selection and SMILES enumeration can improve the performance of ML and DL models when the dataset is severely imbalanced, and SMOTE works the best. Our study established highly accurate supervised learning classification models, which would accelerate the development of USP7 inhibitors. Some guidance was also provided for drug researchers in selecting supervised models and molecular representations as well as handling imbalanced datasets. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00675-8. |
format | Online Article Text |
id | pubmed-9835315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-98353152023-01-13 Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison Shen, Wen-feng Tang, He-wei Li, Jia-bo Li, Xiang Chen, Si J Cheminform Research Ubiquitin-specific-processing protease 7 (USP7) is a promising target protein for cancer therapy, and great attention has been given to the identification of USP7 inhibitors. Traditional virtual screening methods have now been successfully applied to discover USP7 inhibitors aiming at reducing costs and speeding up time in several studies. However, due to their unsatisfactory accuracy, it is still a difficult task to develop USP7 inhibitors. In this study, multiple supervised learning classifiers were built to distinguish active USP7 inhibitors from inactive ligands. Physicochemical descriptors, MACCS keys, ECFP4 fingerprints and SMILES were first calculated to represent the compounds in our in-house dataset. Two deep learning (DL) models and nine classical machine learning (ML) models were then constructed based on different combinations of the above molecular representations under three activity cutoff values, and a total of 15 groups of experiments (75 experiments) were implemented. The performance of the models in these experiments was evaluated, compared and discussed using a variety of metrics. The optimal models are ensemble learning models when the dataset is balanced or severely imbalanced, and SMILES-based DL performs the best when the dataset is slightly imbalanced. Meanwhile, multimodal data fusion in some cases can improve the performance of ML and DL models. In addition, SMOTE, unbiased decoy selection and SMILES enumeration can improve the performance of ML and DL models when the dataset is severely imbalanced, and SMOTE works the best. Our study established highly accurate supervised learning classification models, which would accelerate the development of USP7 inhibitors. Some guidance was also provided for drug researchers in selecting supervised models and molecular representations as well as handling imbalanced datasets. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00675-8. Springer International Publishing 2023-01-11 /pmc/articles/PMC9835315/ /pubmed/36631899 http://dx.doi.org/10.1186/s13321-022-00675-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shen, Wen-feng Tang, He-wei Li, Jia-bo Li, Xiang Chen, Si Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title | Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title_full | Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title_fullStr | Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title_full_unstemmed | Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title_short | Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison |
title_sort | multimodal data fusion for supervised learning-based identification of usp7 inhibitors: a systematic comparison |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835315/ https://www.ncbi.nlm.nih.gov/pubmed/36631899 http://dx.doi.org/10.1186/s13321-022-00675-8 |
work_keys_str_mv | AT shenwenfeng multimodaldatafusionforsupervisedlearningbasedidentificationofusp7inhibitorsasystematiccomparison AT tanghewei multimodaldatafusionforsupervisedlearningbasedidentificationofusp7inhibitorsasystematiccomparison AT lijiabo multimodaldatafusionforsupervisedlearningbasedidentificationofusp7inhibitorsasystematiccomparison AT lixiang multimodaldatafusionforsupervisedlearningbasedidentificationofusp7inhibitorsasystematiccomparison AT chensi multimodaldatafusionforsupervisedlearningbasedidentificationofusp7inhibitorsasystematiccomparison |